×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Cassella James V

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerFeb 15, 2023Sale$8.343,76231,375173,061Feb 16, 2023, 08:48 AM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerJan 30, 2023Sale$8.3510,10684,385176,823Jan 31, 2023, 08:28 AM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerJan 06, 2023Sale$7.252,89320,974186,929Jan 09, 2023, 04:13 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerFeb 14, 2022Sale$3.093,76211,625189,822Feb 16, 2022, 08:01 AM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerJan 05, 2022Sale$3.192,8949,23283,084Jan 07, 2022, 04:17 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerAug 16, 2021Sale$3.288,08626,52285,978Aug 17, 2021, 04:02 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerFeb 16, 2021Sale$7.323,76327,54594,064Feb 17, 2021, 09:27 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerAug 17, 2020Sale$10.374,35445,15176,127Aug 19, 2020, 05:44 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerMar 31, 2019Option Exercise$12.078,835106,63821,165Apr 02, 2019, 04:15 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerApr 17, 2018Sale$20.1810,582213,51030,000Apr 19, 2018, 04:07 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerMar 31, 2018Option Exercise$22.904,418101,17240,582Apr 13, 2018, 04:51 PM
CNCECONCERT PHARMACEUTICALS, INC.Cassella James VChief Development OfficerMar 31, 2018Option Exercise$22.904,418101,17255,582Apr 03, 2018, 04:20 PM
ALXAAlexza Pharmaceuticals Inc.Cassella James VEVP, R&D and CSOMar 29, 2013Option Exercise$4.4243,750193,37562,495Apr 02, 2013, 08:07 PM
ALXAAlexza Pharmaceuticals Inc.Cassella James VEVP, R&D and CSOMar 29, 2013Option Exercise$4.4243,750193,37562,495Apr 02, 2013, 05:28 PM
ALXAAlexza Pharmaceuticals Inc.Cassella James VEVP, R&D and CSODec 26, 2012Sale$4.904,55822,316950Dec 27, 2012, 04:19 PM
ALXAAlexza Pharmaceuticals Inc.Cassella James VEVP, R&D and CSOAug 27, 2012Sale$4.1410,00041,3645,508Aug 29, 2012, 05:39 PM
ALXAAlexza Pharmaceuticals Inc.Cassella James VSVP, Research & DevelopmentJun 06, 2012Sale$0.3446,22215,628157,801Jun 08, 2012, 04:56 PM